This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Determine which index fund delivers stronger rolling returns using straightforward comparisons and key performance signals.
28,161 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Chipmakers led U.S. equities higher, helping the S&P 500 reach a new close. This piece breaks down what moved markets...
Gold prices hovering near $4,000 can prompt questions about safety, liquidity, and potential gains. This guide helps ...
A beloved TV figure's passing reminds us that wealth needs a plan. This article draws finance lessons from a storied ...
As the AI rally continues, XNTK’s 35-stock equal-weight tech approach is being weighed against QQQ’s Nasdaq-100 expos...
In 2026, the iMGP DBi Managed Futures Strategy ETF (DBMF) is delivering an 11% year-to-date gain against a roughly 5%...
Cardano is facing a challenging period. In this guide, you’ll learn how to assess whether the cardano crisis signals ...
As AI adoption accelerates, capital is flowing away from chipmakers toward the data-center backbone—power, cooling, a...
Global markets sold off after leaders offered little concrete trade progress. Investors warn that day one of talks ma...
Religious rhetoric and political theater often spill into our wallets. This piece explains how to separate faith from...
Last year, a notable fintech stock faced a sharp decline. A major fund then exited a $4 million stake, signaling a sh...
Kick off your weekend with focused, actionable investing reads. This guide helps you pick credible sources, turn insi...